anonymous
Guest
anonymous
Guest
Sound off here about Livalo coverage. I'll start. How does Vascepa keep getting wins and Livalo takes it on the chin over and over with the plans? Why is this tolerated? Does the MHC team have ANY relationships at ALL with key people at the big plans? Who is the MHC team accountable to? What happens next year when Crestor goes generic? It's all very frustrating.